Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
The Food and Drug Administration said last week it is strengthening its oversight of medical and pharmaceutical advertising. Commissioner Mark McClellan said the FDA intends to “do all we can under the law” to ensure that prescription-drug ads are “as useful as possible.” Draft guidelines issued last week propose alternatives to the lengthy summaries of risk information in consumer print ads and advise manufacturers how to comply with risk-disclosure rules for broadcast ads.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in